- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07852507
Regional Thoracoabdominal Mobility Responses to Integrated Myofascial Release in Healthy Adults
Acute Effects of Integrated Myofascial Release Therapy on Regional Thoracoabdominal Mobility and Thoracic Excursion in Healthy Adults
his study will investigate the immediate effects of an integrated myofascial release intervention on regional thoracoabdominal mobility in healthy adults. Participants will undergo baseline assessments followed by a single standardized session of integrated myofascial release therapy targeting selected thoracic and abdominal myofascial regions. Thoracoabdominal mobility and thoracic excursion will be reassessed immediately after the intervention. The primary aim is to determine whether integrated myofascial release produces acute changes in regional thoracoabdominal mobility. The study is intended to characterize the immediate biomechanical response to the intervention in healthy adults.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Ece Acar, PhD, PT
- Telefoonnummer: +905457925035
- E-mail: eceacar@karabuk.edu.tr
Studie Locaties
-
-
Karabük Province
-
Karabük, Karabük Province, Turkije (Türkiye)
- Karabuk University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation
-
Contact:
- Ece Acar
- Telefoonnummer: +905457925035
- E-mail: eceacar@karabuk.edu.tr
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria
- Adults aged 18-40 years.
- Apparently healthy individuals without a diagnosed respiratory, cardiovascular, neurological, or musculoskeletal disorder that may affect thoracic or trunk mobility.
- Ability to understand the study procedures and provide written informed consent.
- Ability to complete all pre- and post-intervention assessments. Exclusion Criteria
- Current acute respiratory infection or other acute illness.
- History of thoracic, abdominal, or spinal surgery that may affect thoracoabdominal mobility.
- Current musculoskeletal pain or injury involving the thorax, spine, shoulder girdle, or abdominal region.
- Known neurological or systemic disease affecting mobility or soft tissue function.
- Pregnancy.
- Receipt of manual therapy, myofascial release, or similar treatment targeting the thoracoabdominal region within the recent period defined in the study protocol.
- Any contraindication to manual myofascial release or inability to tolerate the intervention.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Fundamentele wetenschap
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Integrated Myofascial Release
Participants will receive a single standardized session of integrated myofascial release therapy targeting selected thoracic and abdominal myofascial regions. Regional thoracoabdominal mobility and thoracic excursion will be assessed before and immediately after the intervention. |
Participants will receive one standardized session of integrated myofascial release therapy applied manually to selected thoracic and abdominal myofascial regions. The intervention will include sustained, low-load manual techniques directed at the soft tissues and fascial structures of the thoracoabdominal region. The same standardized treatment sequence will be applied to all participants by a trained physiotherapist. Regional thoracoabdominal mobility and thoracic excursion will be assessed immediately before and immediately after the intervention. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Regional Thoracoabdominal Excursion
Tijdsspanne: Baseline and immediately after the intervention
|
Regional thoracoabdominal excursion will be assessed using a tape measure at predefined anatomical levels of the thorax and abdomen. At each level, the difference in circumference between maximal inspiration and maximal expiration will be recorded in centimeters. Changes from baseline to immediately after the integrated myofascial release intervention will be analyzed separately for each anatomical level, allowing comparison of regional mobility responses. |
Baseline and immediately after the intervention
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Algemene publicaties
- Bockenhauer SE, Chen H, Julliard KN, Weedon J. Measuring thoracic excursion: reliability of the cloth tape measure technique. J Am Osteopath Assoc. 2007 May;107(5):191-6.
- Gugliotti M, Rothstein A, Badash E, Cruz R, Cummings C, Karafa B, Santiago T. The immediate effects of myofascial release on lumbar range of motion and flexibility in healthy individuals: A double-blind, randomized sham-controlled trial. J Bodyw Mov Ther. 2025 Jun;42:645-650. doi: 10.1016/j.jbmt.2025.01.052. Epub 2025 Jan 30.
- Nishigaki Y, Mizuguchi H, Takeda E, Koike T, Ando T, Kawamura K, Shimbo T, Ishikawa H, Fujimoto M, Saotome I, Odo R, Omoda K, Yamashita S, Yamada T, Omi T, Matsushita Y, Takeda M, Sekiguchi S, Tanaka S, Fujie M, Inokuchi H, Fujitani J. Development of new measurement system of thoracic excursion with biofeedback: reliability and validity. J Neuroeng Rehabil. 2013 May 20;10:45. doi: 10.1186/1743-0003-10-45.
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- KBU-MFR-THORAX-2026-01
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .